Related Experiment Videos
Hypertensive cardiovascular disease in African Americans
1Division of Nephrology N3W143, University of Maryland Hospital, 22 S. Greene Street, Baltimore, MD 21201, USA.
Insights
Hypertension, a prevalent public health issue in the US, leads to significant cardiovascular disease burdens. Despite its impact, blood pressure remains inadequately controlled nationwide.
Area of Science:
- Public Health
- Cardiovascular Medicine
- Health Economics
Background:
- Hypertension is a leading public health challenge in the United States.
- It is associated with increased cardiovascular diseases, heart disease, and stroke.
- The financial burden of hypertension, its treatment, and related cardiovascular conditions is substantial.
Purpose of the Study:
- To highlight the prevalence and impact of hypertension in the US.
- To underscore the economic and social costs associated with hypertension and cardiovascular diseases.
- To emphasize the issue of poor blood pressure control.
Main Methods:
- This abstract is based on existing epidemiological data and economic analyses.
- It synthesizes information on public health challenges, disease prevalence, and healthcare costs.
- No new experimental methods were employed; it is an observational summary.
Main Results:
- Hypertension is the most common public health challenge in the US.
- Annual costs for hypertension detection and treatment exceed $10 billion.
- Heart disease and stroke, linked to hypertension, represent significant mortality and financial burdens.
Conclusions:
- Effective blood pressure control is crucial for public health in the US.
- Addressing hypertension is essential to mitigate cardiovascular disease and associated economic strain.
- Despite its significance, blood pressure control remains suboptimal nationwide.
Abstract:
Hypertension is the most common public health challenge in the United States because of its prevalence and associated increase in comorbid cardiovascular diseases. Yearly expenses related directly or indirectly to the treatment and detection of hypertension in the United States are approximately $10 billion, excluding the enormous yearly financial burden of $259 billion and the social burden from heart disease and stroke, which remain the first and third leading causes of death, respectively, in the United States. Despite the importance of these observations, blood pressure is poorly controlled in the United States.